BR9708638A - Processos de retardamento de desenvolvimento de tumores associados a cea usando-se anticorpos anti-idiotipo 3h1 - Google Patents

Processos de retardamento de desenvolvimento de tumores associados a cea usando-se anticorpos anti-idiotipo 3h1

Info

Publication number: BR9708638A
Authority: BR; Brazil
Prior art keywords: idiotype; cea; delaying; antibodies; development
Prior art date: 1996-04-12

Application number

BR9708638A

Other languages

English (en)

Inventor

Malaya Chatterjee

Sunil K Chatterjee

Kenneth A Foon

Original Assignee

Malaya Chatterjee

Sunil K. Chatterjee

Kenneth A. Foon

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-12

Filing date

1997-04-11

Publication date

1999-04-13

1997-04-11 Application filed by Malaya Chatterjee, Sunil K. Chatterjee, Kenneth A. Foon filed Critical Malaya Chatterjee

1999-04-13 Publication of BR9708638A publication Critical patent/BR9708638A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR9708638A 1996-04-12 1997-04-11 Processos de retardamento de desenvolvimento de tumores associados a cea usando-se anticorpos anti-idiotipo 3h1 BR9708638A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US63108596A	1996-04-12	1996-04-12
US08/838,692 US6235280B1 (en)	1996-04-12	1997-04-09	Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
PCT/US1997/005953 WO1997038725A1 (en)	1996-04-12	1997-04-11	Methods of delaying development of cea-associated tumors using anti-idiotype antibody 3h1

Publications (1)

Publication Number	Publication Date
BR9708638A true BR9708638A (pt)	1999-04-13

Family

ID=24529708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9708638A BR9708638A (pt)	1996-04-12	1997-04-11	Processos de retardamento de desenvolvimento de tumores associados a cea usando-se anticorpos anti-idiotipo 3h1

Country Status (6)

Country	Link
US (1)	US6235280B1 (pt)
EP (1)	EP0954335A1 (pt)
AU (1)	AU710324B2 (pt)
BR (1)	BR9708638A (pt)
CA (1)	CA2250744A1 (pt)
WO (1)	WO1997038725A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE39760E1 (en) *	1988-03-31	2007-08-07	International Bio-Immune Systems Inc.	Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
US6020145A (en) *	1989-06-30	2000-02-01	Bristol-Myers Squibb Company	Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
US20030035797A1 (en) *	1992-01-27	2003-02-20	Sloan-Kettering Institute For Cancer Research	Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6297041B1 (en) *	1992-03-11	2001-10-02	Institute Of Virology, Slovak Academy Of Sciences	MN gene and protein
US20020041872A1 (en) *	1996-04-12	2002-04-11	Malaya Chatterjee	Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US5776746A (en) *	1996-05-01	1998-07-07	Genitope Corporation	Gene amplification methods
US5853977A (en) *	1996-07-12	1998-12-29	Schering Corporation	Mammalian TNF-α convertases
US20020098190A1 (en) *	1997-06-13	2002-07-25	Malaya Chatterjee	Compositions and methods for treating tumors bearing HMFG and CEA antigens
CA2360382C (en) *	1999-01-13	2011-05-24	Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag	Use of antibodies for the vaccination against cancer
US20040265318A1 (en) *	1999-01-13	2004-12-30	Igeneon Krebs-Immunotherapie Forschungs-und Entwicklungs-AG	Use of antibodies for the vaccination against cancer
FR2793497B1 (fr) *	1999-05-10	2003-04-18	Centre Nat Rech Scient	Anticorps monoclonal dirige contre les cellules de carcinome renal humain
US7147850B2 (en) *	1999-08-18	2006-12-12	Altarex Medical Corp.	Therapeutic binding agents against MUC-1 antigen and methods for their use
WO2002043618A1 (en) *	2000-12-01	2002-06-06	Targent, Inc.	Methods for contemporaneous administration of levamisole and 5-fluorouracil
US7053188B2 (en) *	2002-02-22	2006-05-30	Purdue Research Foundation	Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
WO2003074003A2 (en) *	2002-03-01	2003-09-12	Applied Immune Technologies	Immunogens for treatment of neoplastic and infectious disease
WO2004003229A2 (en) *	2002-06-27	2004-01-08	Aarhus Universitet	Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19
US20040229966A1 (en) *	2003-05-13	2004-11-18	Eastman Kodak Company	Manufacturing process and use for open celled microcellular foam
GB0318247D0 (en) *	2003-08-05	2003-09-10	Royal Veterinary College	Antigen delivery system
US8455188B2 (en) *	2007-01-26	2013-06-04	University Of Louisville Research Foundation, Inc.	Modification of exosomal components for use as a vaccine
US20200306283A1 (en)	2016-06-22	2020-10-01	William Warren HARLESS	Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS54140710A (en)	1978-03-10	1979-11-01	Mitsui Toatsu Chem Inc	Anti-tumor substance and its preparation
US4436728A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
US5171568A (en)	1984-04-06	1992-12-15	Chiron Corporation	Recombinant herpes simplex gb-gd vaccine
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US5407684A (en)	1988-12-30	1995-04-18	Virginia Commonwealth University	Use of DHEA as a medicinal
US5077284A (en)	1988-12-30	1991-12-31	Loria Roger M	Use of dehydroepiandrosterone to improve immune response
US5081235A (en)	1989-07-26	1992-01-14	City Of Hope	Chimeric anti-cea antibody
EP0438803B1 (en)	1990-01-26	1997-03-12	Immunomedics, Inc.	Vaccines against cancer and infectious diseases
WO1991016924A1 (en)	1990-05-10	1991-11-14	The Dana-Farber Cancer Institute	Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells
GB9105992D0 (en)	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
CA2089212C (en)	1992-06-12	2004-01-20	Ken Yamaguchi	Antibodies to human gastrin-releasing peptide precusor and use thereof
AU704829B2 (en)	1994-12-28	1999-05-06	University Of Kentucky	Murine anti-idiotype antibody 3H1

1997
- 1997-04-09 US US08/838,692 patent/US6235280B1/en not_active Expired - Fee Related
- 1997-04-11 WO PCT/US1997/005953 patent/WO1997038725A1/en not_active Ceased
- 1997-04-11 CA CA002250744A patent/CA2250744A1/en not_active Abandoned
- 1997-04-11 BR BR9708638A patent/BR9708638A/pt not_active Application Discontinuation
- 1997-04-11 AU AU26633/97A patent/AU710324B2/en not_active Ceased
- 1997-04-11 EP EP97918555A patent/EP0954335A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
AU710324B2 (en)	1999-09-16
WO1997038725A1 (en)	1997-10-23
AU2663397A (en)	1997-11-07
CA2250744A1 (en)	1997-10-23
EP0954335A1 (en)	1999-11-10
US6235280B1 (en)	2001-05-22

Publication	Publication Date	Title
BR9708638A (pt)	1999-04-13	Processos de retardamento de desenvolvimento de tumores associados a cea usando-se anticorpos anti-idiotipo 3h1
DK1516629T3 (da)	2013-06-03	Humaniseret anti-CD-11a antibodies
IL128406A0 (en)	2000-01-31	Monoclonal antibodies
CY2005008I1 (el)	2009-11-04	Αντισωματα αντι - vegf
DK2302027T3 (da)	2013-12-02	Alfa-amylasemutanter
NO994069L (no)	1999-10-22	Forbindelser for immunoterapi av prostatacancer og fremgangsmate for anvendelse derav
IS4892A (is)	1998-11-10	Styrkt mótefnisblanda
GB9603256D0 (en)	1996-04-17	Antibodies
DE69920897D1 (de)	2004-11-11	Monoklonale antikörper mit verringerter immunisierungsfähigkeit
DE69738312D1 (de)	2008-01-03	Hepatitis b monoklonale antikörper
ATE281836T1 (de)	2004-11-15	Stabilisierte tibolone zubereitungen
NO981454L (no)	1998-10-02	Anti-FAS-antistoffer
NZ501742A (en)	2004-12-24	Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
DE69727301D1 (de)	2004-02-26	Driftzelle
GB9718911D0 (en)	1997-11-12	Monoclonal antibodies
ZA951113B (en)	1995-10-16	Tumor assosiated monoclonal antibody 123av16
AU2225297A (en)	1997-09-16	Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7
HK1028203A (en)	2001-09-21	Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
KR980004025U (ko)	1998-03-30	누출 방지 수단을 갖는 플러밍 파트
GB9615027D0 (en)	1996-09-04	Monoclonal antibodies
ITPT970001V0 (it)	1997-01-16	Barbecue-spiedo biposizionabile
KR970063363U (ko)	1997-12-11	전자레인지의 턴테이블의 회전링
KR980000398U (ko)	1998-03-30	립스틱 케이스
NO962773D0 (no)	1996-07-01	Flytende sluse
KR980001307U (ko)	1998-03-30	노트용 커버

Legal Events

Date	Code	Title	Description
2006-11-28	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2007-04-27	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.PORTANTO, INDEFIRO O PRESENTE PEDIDO.